Comvita Limited Ordinary Shares

CVT.NZX

Consumer Staples

Comvita's origins go back to the 1960s, when research was carried out on a honey and bee products-based therapeutic product range was developed. Exports to England and California commenced in 1989. In 1990 the company was restructured and began focusing on exports to Asia. Comvita shares began quotation on the Unlisted Security Market in September 2002 and the company moved to the NZSX market in 2006.

Market Data

Price

$0.680

+0.0%
Market Cap

$88.3M

P/E Ratio

-0.5x

EPS

$-1.298

Div. Yield

0.00%

52-Week Change

+0.3%

Recent Announcements

21 May 2026 Insider Neutral

Ongoing Disclosure Notices - Directors

Three Comvita Limited directors—Bridget Coates (Chair), Robert Major, and Michael Sang—each acquired ordinary shares on 18-May-26 by participating in the company's renounceable entitlement offer at $0.65 per share, with Coates acquiring 37,802 shares, Major acquiring 34,973 shares, and Sang acquiring 16,801 shares.

21 May 2026 Sph Neutral

SPH Notice - PHC Investments Limited

PHC Investments Limited changed substantial holding from 13.063% to 11.739%.

19 May 2026 Sph Neutral

SPH Notice - Kauri NZ Investment Limited (“Kauri NZ”)

Kauri NZ Investment Limited (“Kauri NZ”) changed substantial holding from 11.291% to 10.146%.

18 May 2026 Sph Neutral

SPH Notice - F&N Ventures Pte. Ltd. (F&N Ventures)

F&N Ventures Pte. Ltd. (F&N Ventures) disclosed a change in substantial holding (19.990%).

18 May 2026 Neutral

Capital Change Notice - Rights Offer & Placement

Comvita Limited issued 59,277,289 ordinary shares on 18 May 2026 through a rights offer (46.1 million shares at $0.65 each) and strategic placement (13.2 million shares at $0.80 each), with F&N Ventures PTE. LTD. as the sole placement participant, representing 84.01% of the company's total share class.

12 May 2026 Neutral

CVT Closes $30m Rights Offer & Confirms $10.5m Placement

Comvita Limited (NZX: CVT) successfully closed a $40.5m capital raise consisting of a $30m rights offer (69% uptake from eligible shareholders) and a $10.5m strategic placement, with Fraser and Neave Limited's subsidiary F&N Ventures acquiring a 19.99% stake as a strategic investor.

7 May 2026 Neutral

Comvita Achieves Minimum Capital Raise Requirement

Comvita Limited has achieved its minimum capital raise requirement of NZ$25 million through its pro-rata Rights Offer, with shareholder take-up of 44% plus F&N's 19.99% subscription commitment. The offer closes at 5pm on 7 May 2026, and the refinancing package is expected to become effective shortly following settlement.

4 May 2026 Neutral

Comvita Rights Offer Closing Date Reminder

Comvita Limited reminds eligible shareholders that its pro-rata Rights Offer closes at 5:00pm on 7 May 2026 NZST, offering 1 new share for every 1.53 existing shares at NZ$0.65 per share as part of a capital raise to facilitate bank refinancing, with F&N Ventures (Fraser and Neave subsidiary) joining as a strategic investor.

29 Apr 2026 Neutral

Comvita announces change to Board of Directors

Comvita Limited (NZX: CVT) announces that Director Yawen Wu from China Resources Enterprise Limited has resigned from the Board effective 29 April 2026, with her alternative Ching Ho (Alfred) Luk also departing after providing counsel during the company's strategic reset.

23 Apr 2026 Neutral

Comvita Rights Offer Opens

Comvita Limited (NZX: CVT) opened a pro-rata rights offer on 23 April 2026 to raise up to NZ$30 million for bank refinancing, with eligible shareholders able to subscribe for 1 new share per 1.53 existing shares at NZ$0.65 per share (a 4.4% discount to the last traded price). Fraser and Neave Limited's subsidiary F&N Ventures will partially underwrite the offer and join as a strategic investor.

Get real-time alerts for CVT

Receive AI-powered earnings summaries and instant notifications when Comvita Limited Ordinary Shares releases results.

Register Free